Trump officials reportedly set to tie Tylenol to autism risk
The Trump administration is reportedly set to announce a link between the active ingredient in Tylenol, acetaminophen, and an increased risk of autism when used during pregnancy. Officials plan to advise pregnant women against using Tylenol unless for treating a fever. The announcement is expected to be made Monday, with President Trump calling it a significant revelation regarding autism. In addition, the administration is likely to promote leucovorin, a prescription medication used primarily in cancer treatment, as a potential treatment for autism.
This forthcoming announcement challenges current medical guidelines, which generally consider Tylenol safe during pregnancy. The news follows reports that the administration, led by Health Secretary Robert F. Kennedy Jr., has been investigating environmental factors contributing to the rise in autism rates. However, the scientific community remains divided, with previous studies and court rulings showing no conclusive causal link between prenatal acetaminophen use and autism risk.
The administration’s announcement would mark the first time the US government officially ties acetaminophen in pregnancy to autism risk, signaling a major shift in public health recommendations and possibly influencing prenatal care advice globally.
